1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Acadia Healthcare entered a new credit agreement with JPMorgan Chase Bank as administrative agent, providing a $1 billion revolving facility and a $650 million term loan, both maturing February 28, 2030. The company used the proceeds to refinance obligations under its prior credit agreement, which it terminated, and the new facilities carry floating interest rates and financial covenants.
New $1 billion revolving facility and $650 million term loan, both maturing February 28, 2030
Proceeds used to refinance obligations under the Existing Credit Agreement, which was dated March 17, 2021 and scheduled to mature March 17, 2026
Borrowings bear floating rates: SOFR plus 1.375% to 2.250%, or base rate plus 0.375% to 1.250%, based on net leverage
Covenants include a Consolidated Total Net Leverage Ratio of no more than 5.0 to 1.0 and Interest Coverage of at least 3.0 to 1.0
ABM Industries entered an amended and restated credit agreement dated February 26, 2025, with Bank of America as administrative agent. The facility provides $1.6 billion of revolving commitments and $600 million of term facility commitments, both with a five-year term maturing February 26, 2030, and it refinances the company's prior credit agreement from 2017.
Revolving credit commitments of $1.6 billion and term facility commitments of $600 million, maturing February 26, 2030
Borrowings priced at a margin tied to the total net leverage ratio over Term SOFR or a base rate; commitment fee of 0.200% to 0.400%
Financial covenants include maximum total net leverage of 5.00 to 1.00, maximum secured net leverage of 4.00 to 1.00, and minimum interest coverage of 1.50 to 1.00
Initial term loan proceeds were used to refinance the Original Credit Agreement, repay part of revolving borrowings and pay transaction costs
Emerson agreed on February 25, 2025 to sell €500 million of 3.000% notes due 2031, €500 million of 3.500% notes due 2037, and $500 million of 5.000% notes due 2035, with closing expected March 4, 2025. The company expects net proceeds of about $1,536.7 million, to be used for general corporate purposes, commercial paper repayment, and part of the purchase price for its proposed acquisition of AspenTech; the filing notes the notes offering is not conditioned on that acquisition closing.
Euro notes: €500 million 3.000% due 2031 sold at 99.561% of principal and €500 million 3.500% due 2037 sold at 99.270%.
Dollar notes: $500 million 5.000% due 2035 sold at 99.454% of principal.
Expected net proceeds of about $1,536.7 million, before offering expenses, with closing expected March 4, 2025.
Proceeds partly fund the proposed purchase of AspenTech shares not already owned by Emerson, which the filing says may not be completed on the anticipated terms or at all.
Gen Digital issued $950 million of 6.250% Senior Notes due 2033 on February 28, 2025, in a private offering. The company said it used the proceeds, along with cash on hand, to repurchase all of its outstanding 5.00% Senior Notes due 2025 and pay accrued interest on them. The filing describes a refinancing that replaces near-term debt with notes maturing in 2033, though it does not report a change in total debt.
Notes: $950 million principal, 6.250% annual interest, paid semi-annually, maturing April 1, 2033
Interest payments begin October 1, 2025; the company may redeem some notes before April 1, 2028 at a make-whole price
Proceeds plus cash on hand used to repurchase all outstanding 5.00% Senior Notes due 2025
Notes sold only to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S
The Cheesecake Factory issued $575 million of 2.00% convertible senior notes due March 15, 2030, including $75 million from the full exercise of the initial purchasers' option. The company's press release says it plans to use part of the net proceeds to repurchase $276 million of its 0.375% convertible notes due 2026 and about 2.4 million common shares, which may affect the trading price of its stock and the initial conversion price.
Notes issued February 28, 2025: $575 million principal, including $75 million from the full exercise of the initial purchasers' option; interest is payable semi-annually beginning September 15, 2025.
Initial conversion price is about $70.73 per share, a premium of about 30.0% over the $54.41 closing price on February 25, 2025; up to 10,567,868 shares may be issued on conversion at the maximum conversion rate.
Press release estimates net proceeds of about $558.5 million with the option fully exercised; about $290.0 million is earmarked to repurchase $276.0 million of 2026 notes and about $130.0 million to repurchase about 2.4 million shares.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.